HHS report on gender-affirming care draws criticism from experts

September 30, 2026 Dr. Michael Lee – Health Editor Health

The U.S. Department of Health and Human Services released an unreviewed report in August 2026 titled “Where the Clinic Meets the Movement: Does Gender Ideology Arm Left-Wing Authoritarian Psychology?” The document claims that support for gender-affirming care is linked to left-wing authoritarianism and political violence. Authored in part by evolutionary biologist Colin Wright of the Manhattan Institute, the paper has drawn sharp criticism from some experts regarding its methodology, lack of peer review, and absence of underlying data.

  • The HHS report asserts that gender-affirming care may act as an ideological accelerant for political violence, though its authors rely on speculative framing using the word “may.”
  • The document lacks independent peer review, public funding disclosures, and accessible underlying datasets, departing from standard scientific research protocols.
  • Experts emphasize that established clinical standards for transgender patients remain anchored in peer-reviewed medical consensus, while empirical data shows transgender people are far more likely to be targets of violence rather than perpetrators.

Methodological Concerns and the Absence of Peer Review

Published in August 2026, the HHS document bypassed traditional scientific validation channels. The report has not undergone peer review, and its funding sources and underlying data remain withheld from the public. These omissions stand in direct contrast to established best practices in scientific research. Co-author Colin Wright stated that the paper will eventually be submitted to a scientific journal, defending the current release by asserting that the absence of prior peer review does not equate to pseudoscience.

Adrian Shanker, who served as deputy assistant secretary for health policy at HHS during the Biden administration, noted that previous departmental reports typically relied on generalist science writing firms under longstanding, non-political contracts. Shanker characterized the current trajectory as a departure from standard procedure, stating that the administration appears to partner with politically aligned researchers and think tanks to produce reports designed to meet predetermined political conclusions rather than objective scientific outcomes.

Framing of Gender-Affording Standards and Political Intentions

The report uses the term “gender ideology” interchangeably with “gender-affirming care,” which represents the accepted medical and mental health standard of care for treating transgender patients. Experts interviewed regarding the publication point out that the framing attempts to delegitimize transgender identity by associating medical treatment protocols with political extremism. The text argues that gender ideology provides a conceptual framework that guides left-wing authoritarian psychology toward perceived adversaries.

HHS report on gender-affirming care draws criticism from experts
Photo: wvasfm.org

Defending the terminology, Wright stated in correspondence that the term accurately captures the reality that debates surrounding transgender issues involve fundamental belief systems rather than isolated factual disputes. At the same time, public health data consistently demonstrates that transgender populations face heightened risks of victimization. Empirical studies show that transgender people are far more likely to be targets of violence rather than perpetrators, contradicting the narrative advanced in recent federal directives regarding “gender ideology extremism.”

Administrative Context and Institutional Implications

The release of the report follows ongoing efforts by President Trump, Robert F. Kennedy Jr., and allied officials to emphasize transparency and gold-standard scientific research within federal health agencies. However, the publication’s conclusions and the collaborative role of the Manhattan Institute—a right-wing policy think tank active in campaigns against diversity, equity, and inclusion initiatives—have generated substantial skepticism across the scientific community.

HHS did not respond to interview requests regarding the report’s preparation or data availability. As federal health agencies manage these policy shifts, patients, clinicians, and researchers seeking guidance on evidence-based care protocols often consult vetted medical specialists and clinical guidelines to ensure treatments align with rigorous empirical data and established safety standards.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Keep reading